Abstract
The prognosis for patients presenting with advanced head and neck squamous cell carcinoma using ‘standard’ treatment approaches, such as surgery followed by radiotherapy or radiotherapy alone, remains poor. Additionally, patients often lose their voice or swallowing ability when a primary surgical approach is used. Although systemic chemotherapy, when combined concurrently with radiotherapy, appears to be superior to radiation alone, the use of neoadjuvant or adjuvant systemic chemotherapy has not improved survival when combined with either surgery or radiotherapy. Even with the use of concurrent systemic chemotherapy and radiotherapy, the majority of the patients still succumb to their disease, usually failing locoregionally. Among the newer strategies being explored is the use of supradose intra-arterial chemotherapy (ie, cisplatin) with current radiotherapy. Acronymed ‘RADPLAT,’ this novel therapeutic approach delivers supradoses of weekly cisplatin chemotherapy with concurrent radiotherapy with acceptable toxicity, high locoregional tumor control rates, and very promising survival results. In addition, the RADPLAT approach allows for the preservation of organ function. This article reviews the evolution of the RADPLAT concept from a phase I trial to a recently completed Radiation Therapy Oncology Group trial confirming its feasibility in a multi-institutional setting.
Similar content being viewed by others
References
El-Sayed S, Nelson N: Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J Clin Oncol 1996, 14:838–847. Important review article.
Eckman WW, Patlak CS, Fenstermacher JD: A critical evaluation of the principles governing the advantages of intra-arterial infusions. J Pharmacokinet Biopharm 1974, 2:257–285.
Wolpert SM, Kwan ES, Heros D, et al.: Selective delivery of chemotherapeutic agents with a new catheter system. Radiology 1988, 166:547–549.
Elferink WJF, van der Vijah IK, Pinedo HM: Interaction of cisplatin and carboplatin with sodium thiosulfate: reaction rates and protein binding. Clin Chem 1986, 32:642–645.
Shea M, Koziol JA, Howell SB: Kinetics of sodium thiosulfate, a cisplatin neutralizer. Clin Pharmacol Ther 1984, 35:419–425.
Kerber CW, Wong WHM, Robbins KT: A treatment of head and neck cancer by direct arterial infusion. In Interventional Neuroradiology Strategies and Practical Techniques. Edited by Connors B. Philadelphia: WB Saunders; 1988:358–371.
Robbins KT, Storniolo AMS, Kerber C, et al.: Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer. J Clin Oncol 1994, 12:2113–2120. See annotation for [8] below.
Robbins KT, Storniolo AMS, Hryniuk WH, Howell SB: Decadose effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract: part II, clinical studies. Laryngoscope 1996, 106:37–42. With [7] above, one of the initial reported studies establishing RADPLAT dosing and schedule.
Robbins KT, Vicario D, Seagren S, et al.: A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994, 168:419–421.
Robbins KT, Fontanesi J, Wong FSH, et al.: A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx. Arch Otolaryngol 1996, 122:853–857.
Robbins KT, Kumar P, Regine WF, et al.: Efficacy of supradose intra-arterial targeted (SIT) cisplatin (P) and concurrent radiation therapy (RT) in the treatment of unresectable stage III-IV head and neck carcinoma: the Memphis experience. Int J Radiat Oncol Biol Phys 1997, 38:263–271. See annotation for [14] below.
Robbins KT, Kumar P, Weisman RA, et al.: Phase II trial of targeted supradose cisplatin (DDP) and concomitant radiation therapy (RT) for patients with stage III-IV head and neck cancer [abstract]. Proc ASCO 1996, 15:323.
Robbins KT, Pellitteri P, Vicario D, et al.: Targeted infusions of supradose cisplatin with systemic neutralization for carcinomas invading the temporal bone. Skull Base Surg 1996, 6:53–60.
Robbins KT, Wong FS, Kumar P, et al.: Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999, 125:670–675. This report, along with [11] above, provides evidence that corroborates the RADPLAT approach.
Ahmed KA, Robbins KT, Wong F, Salazar JE: Efficacy of concomitant chemoradiation and surgical salvage for N3 nodal disease associated with upper aerodigestive tract carcinoma. Laryngoscope 2000, 110:1789–1793.
Shannon KF, Robertson JT, Kumar P, Robbins KT: Intra-arterial cisplatin and concurrent radiotherapy in the treatment of paranasal sinus cancer [abstract]. Skull Base Surg 1999, 9:28.
Samant S, Vieira F, Hanchett C, Robbins KT: Bone or cartilage invasion by advanced head and neck cancer: intra-arterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation [abstract]. Proc Int Head Neck Cancer 2000, 5:78 (abstract 047).
Kumar P, Wan J, Vieira F, et al.: The prophylactic use of pentoxifylline in the therapy of stage IV-N2-3 head and neck squamous cell carcinoma treated with supradose intra-arterial targeted cisplatin and concurrent radiation therapy: preliminary results of a pilot study [abstract. Int J Radiat Oncol Biol Phys 1999, 45:279.
Robbins KT, Samant S: Concomitant intra-arterial (IA) cisplatin, abbreviated radiotherapy and limited surgery for intermediate oral and oropharyngeal cancers [abstract]. Proc Int Head Neck Cancer 2000, 5.
Robbins KT, Harris J, Kumar P, et al.: Targeted chemoradiation (RADPLAT) for T4 carcinoma of the upper aerodigestive tract (RTOG 96-15): interim analysis of a multi-institutional trial [abstract]. Proc Int Head Neck Cancer 2000, 5.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kumar, P., Robbins, K.T. Treatment of advanced head and neck cancer with intra-arterial cisplatin and concurrent radiation therapy: The ‘RADPLAT’protocol. Curr Oncol Rep 3, 59–65 (2001). https://doi.org/10.1007/s11912-001-0044-1
Issue Date:
DOI: https://doi.org/10.1007/s11912-001-0044-1